ARKAY
Get informed when a big investor buys or sells
+ FollowUndervalued by 18.9% based on the discounted cash flow analysis.
| Market cap | $4.77 Billion |
|---|---|
| Enterprise Value | $8.37 Billion |
| Dividend Yield | $4.18 (6.41%) |
| Earnings per Share | $0.8 |
| Beta | 0.96 |
| Outstanding Shares | 75,655,533 |
| P/E Ratio | 330.29 |
|---|---|
| PEG | 834.54 |
| Price to Sales | 0.54 |
| Price to Book Ratio | 0.34 |
| Enterprise Value to Revenue | 0.94 |
| Enterprise Value to EBIT | 20.7 |
| Enterprise Value to Net Income | 139 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.85 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $52,767▼ 80.72% |
| Investors Holding | 3▼ 2.00% |
No data
Arkema SA engages in manufacturing and supply of chemical products. It operates through followings segments: High Performance Materials, Industrials Specialties and Coating Solutions. The High Performance Materials segment includes the T...